Search Results - "Tsang, Richard W"

Refine Results
  1. 1
  2. 2

    Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis by Sawka, Anna M, Thabane, Lehana, Parlea, Luciana, Ibrahim-Zada, Irada, Tsang, Richard W, Brierley, James D, Straus, Sharon, Ezzat, Shereen, Goldstein, David P

    Published in Thyroid (New York, N.Y.) (01-05-2009)
    “…The risk of second primary malignancies (SPMs) associated with cancer therapies is an important concern of thyroid cancer survivors and physicians. Our…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical Outcome by TSANG, Richard W, GOSPODAROWICZ, Mary K, PINTILIE, Melania, WELLS, Woodrow, HODGSON, David C, SUN, Alexander, CRUMP, Michael, PATTERSON, Bruce J

    Published in Journal of clinical oncology (15-11-2003)
    “…Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is a distinct lymphoma with unique clinicopathologic features. We…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study by Knobel, David, Zouhair, Abderrahim, Tsang, Richard W, Poortmans, Philip, Belkacémi, Yazid, Bolla, Michel, Oner, Fazilet Dinçbas, Landmann, Christine, Castelain, Bernard, Ozsahin, Mahmut

    Published in BMC cancer (05-05-2006)
    “…Solitary plasmacytoma (SP) of the bone is a rare plasma-cell neoplasm. There are no conclusive data in the literature on the optimal radiation therapy (RT)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Hodgkin Lymphoma Across the Age Spectrum: Epidemiology, Therapy, and Late Effects by Punnett, Angela, MD, FRCPC, Tsang, Richard W., MD, FRCPC, Hodgson, David C., MD, MPH, FRCPC

    Published in Seminars in radiation oncology (2010)
    “…The treatment of Hodgkin lymphoma is one of the success stories of modern medicine. There is a unified pathologic classification schema, a noninvasive staging…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Patients' experiences following local-regional recurrence of thyroid cancer: A qualitative study by Misra, Shikha, Meiyappan, Soumia, Heus, Lineke, Freeman, Jeremy, Rotstein, Lorne, Brierley, James D., Tsang, Richard W., Rodin, Gary, Ezzat, Shereen, Goldstein, David P., Sawka, Anna M.

    Published in Journal of surgical oncology (01-07-2013)
    “…Background and Objective The psychosocial impact of local–regional thyroid cancer recurrence is not known. The aim of this study was to explore thyroid cancer…”
    Get full text
    Journal Article
  13. 13

    Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review by Sawka, Anna M, Ibrahim-Zada, Irada, Galacgac, Philip, Tsang, Richard W, Brierley, James D, Ezzat, Shereen, Goldstein, David P

    Published in Thyroid (New York, N.Y.) (01-10-2010)
    “…Dietary iodine is often restricted before radioactive iodine (RAI) scanning or treatment of well-differentiated thyroid cancer. Our objective was to examine…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16

    External Beam Radiation Therapy for Thyroid Cancer by Brierley, James D., MBBS, FRCP, FRCR, FRCP(C), Tsang, Richard W., MD, FRCP(C)

    “…This article discusses the role of external beam radiotherapy (XRT) in the management of well-differentiated thyroid cancer (WDTC), medullary thyroid cancer,…”
    Get full text
    Journal Article
  17. 17

    A pilot study examining Toronto-area family physician perspectives on thyroid neoplasm evaluation by Kundra, Arjun, Goldstein, David P, Wintemute, Kimberly, Ghai, Sangeet, Tsang, Richard W, Gupta, Karuna, Mutasingwa, Donatus R, Weissberger, Jeff, Huszti, Ella, Brown, Patrick, Jiang, Huan, Sawka, Anna M

    “…The incidence of thyroid cancer (TC) is known to be very high in the Greater Toronto Area of Ontario, Canada. We performed a pilot survey study examining…”
    Get full text
    Journal Article
  18. 18

    A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors by Sawka, Anna M., Lea, Jane, Alshehri, Bandar, Straus, Sharon, Tsang, Richard W., Brierley, James D., Thabane, Lehana, Rotstein, Lorne, Gafni, Amiram, Ezzat, Shereen, Goldstein, David P.

    Published in Clinical endocrinology (Oxford) (01-04-2008)
    “…Summary Background  For patients with well‐differentiated thyroid carcinoma (WDTC), the gonadal effects of radioactive iodine (RAI) therapy is an important…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk by Koh, Eng-Siew, Tran, Tu Huan, Heydarian, Mostafa, Sachs, Rainer K, Tsang, Richard W, Brenner, David J, Pintilie, Melania, Xu, Tony, Chung, June, Paul, Narinder, Hodgson, David C

    Published in Radiation oncology (London, England) (15-03-2007)
    “…Hodgkin's lymphoma (HL) survivors who undergo radiotherapy experience increased risks of second cancers (SC) and cardiac sequelae. To reduce such risks,…”
    Get full text
    Journal Article